Heparin administration leads to rapid decrease in plasma matrix metalloproteinase-9

被引:1
|
作者
Lee, Regent [1 ]
Adlam, David [1 ]
Antoniades, Charalambos [1 ]
Digby, Janet E. [1 ]
Kharbanda, Rajesh K. [1 ]
Choudhury, Robin P. [1 ]
Channon, Keith M. [1 ]
机构
[1] Univ Oxford, Dept Cardiovasc Med, Oxford OX1 2JD, England
基金
英国惠康基金;
关键词
Matrix metalloproteinase-9; MMP9; Heparin; Coronary artery disease; Biomarker; Preanalytic issue; MATRIX; INHIBITOR; BLOOD;
D O I
10.1016/j.ijcard.2012.06.105
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:212 / 213
页数:2
相关论文
共 50 条
  • [21] Matrix Metalloproteinase-3 but Not Matrix Metalloproteinase-9, Implicated in the Manifestation of Chronic Periodontitis
    Razavi, Pouyan
    Rezaee, Seyed Abdolrahim
    Akhondian, Salehe
    Asgari, Nastaran
    Fatemi, Kazem
    Mohajertehran, Farnaz
    REPORTS OF BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2023, 11 (04): : 656 - 662
  • [22] Relationship of plasma matrix metalloproteinase-9 and hematoma expansion in acute hypertensive cerebral hemorrhage
    Yang, Qingwei
    Zhuang, Xiaorong
    Peng, Feng
    Zheng, Weihong
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2016, 126 (03) : 213 - 218
  • [23] Matrix Metalloproteinase-9 as a Marker for Acute Ischemic Stroke: A Systematic Review
    Ramos-Fernandez, Maria
    Bellolio, M. Fernanda
    Stead, Latha G.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2011, 20 (01) : 47 - 54
  • [24] Mutant matrix metalloproteinase-9 reduces postoperative peritoneal adhesions in rats
    Atta, Hussein
    El-Rehany, Mahmoud
    Roeb, Elke
    Abdel-Ghany, Hend
    Ramzy, Maggie
    Gaber, Shereen
    INTERNATIONAL JOURNAL OF SURGERY, 2016, 26 : 58 - 63
  • [25] Plasma levels of matrix metalloproteinase-9 (MMP-9) are associated with cognitive performance in patients with schizophrenia
    Kudo, Noriko
    Yamamori, Hidenaga
    Ishima, Tamaki
    Nemoto, Kiyotaka
    Yasuda, Yuka
    Fujimoto, Michiko
    Azechi, Hirotsugu
    Niitsu, Tomihisa
    Numata, Shusuke
    Ikeda, Manabu
    Iyo, Masaomi
    Ohmori, Tetsuro
    Fukunaga, Masaki
    Watanabe, Yoshiyuki
    Hashimoto, Kenji
    Hashimoto, Ryota
    NEUROPSYCHOPHARMACOLOGY REPORTS, 2020, 40 (02) : 150 - 156
  • [26] Matrix Metalloproteinase-9 Gene and Bipolar Mood Disorder
    Janusz K. Rybakowski
    Maria Skibinska
    Anna Leszczynska-Rodziewicz
    Leszek Kaczmarek
    Joanna Hauser
    NeuroMolecular Medicine, 2009, 11 : 128 - 132
  • [27] Suppression of matrix metalloproteinase-9 by 4-methylumbelliferone
    Nakamura, Rika
    Kuwabara, Hiroko
    Yoneda, Masahiko
    Yoshihara, Shuichi
    Ishikawa, Takashi
    Miura, Tomisato
    Nozaka, Hiroyuki
    Nanashima, Naoki
    Sato, Tatsusuke
    Nakamura, Toshiya
    CELL BIOLOGY INTERNATIONAL, 2007, 31 (09) : 1022 - 1026
  • [28] Environmental arsenic exposure and serum matrix metalloproteinase-9
    Jefferey L Burgess
    Margaret Kurzius-Spencer
    Mary Kay O'Rourke
    Sally R Littau
    Jason Roberge
    Maria Mercedes Meza-Montenegro
    Luis Enrique Gutiérrez-Millán
    Robin B Harris
    Journal of Exposure Science & Environmental Epidemiology, 2013, 23 : 163 - 169
  • [29] Matrix Metalloproteinase-9 Gene and Bipolar Mood Disorder
    Rybakowski, Janusz K.
    Skibinska, Maria
    Leszczynska-Rodziewicz, Anna
    Kaczmarek, Leszek
    Hauser, Joanna
    NEUROMOLECULAR MEDICINE, 2009, 11 (02) : 128 - 132
  • [30] Asthma remodeling: The pathogenic role of matrix metalloproteinase-9
    Farhat, Amgad A.
    Mohamad, Ahmad S.
    Shareef, Mohamad M.
    Attia, Ghada Atef
    Eid, Manal A.
    Taha, Rehab W.
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2014, 63 (04): : 755 - 759